The findings from the present study confirm previous report, which showed that the DC + TL + TRF treatment approach inhibited tumor growth and metastasis by promoting Th1 immune response through stimulating production of interferon-gamma (IFN-γ) and interleukin-12 (IL-12) [19,24,37]. The gene discussed is IFNG; the disease is neoplasm.